First Genetic Screen of Pigs Using ENU

Using the mutagenic chemical N-ethyl-N-nitrosourea, researchers confirm the role of a gene in a piglet deformity and identify potential models for human diseases.

Written byAshley Yeager
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

These images show mutant Bama miniature pigs, with black coat denoting the mutations in pigs on the left and short limbs and small body size of those on the right. HAI ET AL., ELIFE, 2017For the first time, researchers report the use of the mutagenic chemical N-ethyl-N-nitrosourea (ENU) to conduct a genetic screen in pigs. The data reveal mutations associated with splay leg, which makes it difficult for piglets to stand and walk, and also with inner ear malfunctions that mimic a similar condition in humans.

The results, published June 22 in eLife, suggest that mutagenesis caused by ENU could be used as an alternative to worms, fruit flies, and rodents to model human disease, and as a tool for the pork industry.

“Pigs are an important source of meat worldwide and are considered as preferred models of various human diseases,” study coauthor Jianguo Zhao of the State Key Laboratory of Stem Cell and Reproductive Biology in Beijing tells The Scientist in an email. Pigs are also similar to humans in organ size, along with other anatomical and physiological characteristics, and in their genetics. However, generating mutations with N-ethyl-N-nitrosourea and then linking changes in behavior and appearance to particular mutations has never been done in pigs before.

N-ethyl-N-nitrosourea is a potent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies